SWM
Sugarloaf Wealth Management’s Alaunos Therapeutics TCRT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $322 | Sell |
169
-266
| -61% | -$507 | ﹤0.01% | 669 |
|
2024
Q3 | $1.4K | Sell |
435
-3,930
| -90% | -$12.7K | ﹤0.01% | 626 |
|
2024
Q2 | $3.05K | Hold |
4,365
| – | – | ﹤0.01% | 561 |
|
2024
Q1 | $7.9K | Sell |
4,365
-61,135
| -93% | -$111K | ﹤0.01% | 504 |
|
2023
Q4 | $4.63K | Sell |
65,500
-10,000
| -13% | -$707 | ﹤0.01% | 553 |
|
2023
Q3 | $9.95K | Hold |
75,500
| – | – | ﹤0.01% | 468 |
|
2023
Q2 | $38.5K | Hold |
75,500
| – | – | 0.01% | 320 |
|
2023
Q1 | $47.6K | Buy |
75,500
+5,000
| +7% | +$3.15K | 0.01% | 298 |
|
2022
Q4 | $45.8K | Sell |
70,500
-8,550
| -11% | -$5.55K | 0.01% | 299 |
|
2022
Q3 | $136K | Buy |
79,050
+2,500
| +3% | +$4.3K | 0.03% | 161 |
|
2022
Q2 | $95K | Buy |
+76,550
| New | +$95K | 0.02% | 190 |
|
2022
Q1 | – | Sell |
-64,050
| Closed | -$70K | – | 764 |
|
2021
Q4 | $70K | Buy |
64,050
+29,800
| +87% | +$32.6K | 0.02% | 241 |
|
2021
Q3 | $62K | Hold |
34,250
| – | – | 0.02% | 245 |
|
2021
Q2 | $90K | Buy |
34,250
+10,000
| +41% | +$26.3K | 0.02% | 200 |
|
2021
Q1 | $87 | Hold |
24,250
| – | – | 0.03% | 205 |
|
2020
Q4 | $61K | Hold |
24,250
| – | – | 0.02% | 235 |
|
2020
Q3 | $61K | Hold |
24,250
| – | – | 0.02% | 210 |
|
2020
Q2 | $80K | Hold |
24,250
| – | – | 0.03% | 182 |
|
2020
Q1 | $59K | Hold |
24,250
| – | – | 0.03% | 207 |
|
2019
Q4 | $114K | Buy |
+24,250
| New | +$114K | 0.05% | 163 |
|